Tumor Microenvironment in the Brain

In addition to malignant cancer cells, tumors contain a variety of different stromal cells that constitute the tumor microenvironment. Some of these cell types provide crucial support for tumor growth, while others have been suggested to actually inhibit tumor progression. The composition of tumor microenvironment varies depending on the tumor site. The brain in particular consists of numerous specialized cell types such as microglia, astrocytes, and brain endothelial cells. In addition to these brain-resident cells, primary and metastatic brain tumors have also been shown to be infiltrated by different populations of bone marrow-derived cells. The role of different cell types that constitute tumor microenvironment in the progression of brain malignancies is only poorly understood. Tumor microenvironment has been shown to be a promising therapeutic target and diagnostic marker in extracranial malignancies. A better understanding of tumor microenvironment in the brain would therefore be expected to contribute to the development of improved therapies for brain tumors that are urgently required due to a poor availability of treatments for these malignancies. This review summarizes some of the known interactions between brain tumors and different stromal cells, and also discusses potential therapeutic approaches within this context.

[1]  M. Moses,et al.  Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications. , 2006, EXS.

[2]  Tarik Tihan,et al.  The hypoxic response of tumors is dependent on their microenvironment. , 2003, Cancer cell.

[3]  P. Sawchenko,et al.  Bone Marrow-Derived Cells that Populate the Adult Mouse Brain Preserve Their Hematopoietic Identity , 2003, The Journal of Neuroscience.

[4]  M J Gleason,et al.  Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Berger,et al.  Intracranial Microenvironment Reveals Independent Opposing Functions of Host αVβ3 Expression on Glioma Growth and Angiogenesis* , 2006, Journal of Biological Chemistry.

[6]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[7]  S. Nag,et al.  Morphology and molecular properties of cellular components of normal cerebral vessels. , 2003, Methods in molecular medicine.

[8]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[9]  T. Shono,et al.  Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  B. Badie,et al.  Impaired capacity for upregulation of MHC class II in tumor‐associated microglia , 2005, Glia.

[11]  P. Ricciardi-Castagnoli,et al.  Microglial cells induce cytotoxic effects toward colon carcinoma cells: Measurement of tumor cytotoxicity with a γ‐glutamyl transpeptidase assay , 1997, International journal of cancer.

[12]  J. Tímár,et al.  Circulating bone marrow‐derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[13]  Jochen Herms,et al.  Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis , 2009, Glia.

[14]  Harold E. Dvorak,et al.  Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.

[15]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[16]  M. Colombo,et al.  Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. , 2003, Blood.

[17]  J. Fukushi,et al.  NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. , 2004, Molecular biology of the cell.

[18]  D. Gutmann,et al.  Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. , 2007, Human molecular genetics.

[19]  A. Gregory Sorensen,et al.  Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.

[20]  G. Nicolson,et al.  Brain metastasis: role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system. , 1996, Current topics in microbiology and immunology.

[21]  D. Hicklin,et al.  Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. , 2007, Cancer research.

[22]  A. Castelló,et al.  5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma , 1998, Journal of Neuroimmunology.

[23]  T. Iwama,et al.  Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. , 2009, International journal of oncology.

[24]  D. Gisselsson,et al.  Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Vogel,et al.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.

[27]  B Swolin,et al.  Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.

[28]  V. Tse,et al.  Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone marrow-derived endothelial precursor cells into brain tumors , 2005, Neurological research.

[29]  T. Postolache,,et al.  Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.

[30]  R. Kerbel,et al.  Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. , 2003, Cancer research.

[31]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[32]  A. Koretsky,et al.  Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model , 2009, Clinical & Experimental Metastasis.

[33]  J. Kuratsu,et al.  Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas , 2008, The Journal of pathology.

[34]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[35]  S. Brem,et al.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.

[36]  Pieter Wesseling,et al.  Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option , 2004, Clinical Cancer Research.

[37]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[38]  T. Seike,et al.  Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis , 2010, Clinical & Experimental Metastasis.

[39]  W. Hickey,et al.  Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.

[40]  P. Rieckmann,et al.  Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.

[41]  S. Leung,et al.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.

[42]  W. Stallcup,et al.  NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and α3β1 Integrin , 2004 .

[43]  Robert S. Kerbel,et al.  The multifaceted circulating endothelial cell in cancer: towards marker and target identification , 2006, Nature Reviews Cancer.

[44]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[45]  J. Price,et al.  Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[46]  W. Stallcup,et al.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan , 2004, Angiogenesis.

[47]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[48]  I. Weissman,et al.  Incorporation of Bone Marrow-derived Flk-1-expressing CD34+ Cells in the Endothelium of Tumor Vessels in the Mouse Brain , 2004, Neurosurgery.

[49]  H. Tsuda,et al.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.

[50]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[51]  I. Weissman,et al.  Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. , 2008, Stem cells and development.

[52]  B. Melchior,et al.  CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.

[53]  V. ter meulen,et al.  Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Nikiforova,et al.  Molecular diagnostics of gliomas. , 2011, Archives of pathology & laboratory medicine.

[55]  M. Frotscher,et al.  Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment , 2001, Nature Medicine.

[56]  W. Hop,et al.  Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas , 2007, Annals of neurology.

[57]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[58]  B. Badie,et al.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.

[59]  R. Jain,et al.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.

[60]  G. Bergers,et al.  The bone marrow constitutes a reservoir of pericyte progenitors , 2006, Journal of leukocyte biology.

[61]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[62]  K. Williams,et al.  Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates. , 2009, The American journal of pathology.

[63]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[64]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[65]  L. Salford,et al.  Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. , 2012, Neurosurgery.

[66]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[67]  N. Sibson,et al.  The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.

[68]  G. Mckhann,et al.  Defective Receptor Expression and Dendritic Cell Differentiation of Monocytes in Glioblastomas , 2006, Neurosurgery.

[69]  M. Berens,et al.  Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.

[70]  W. Fierz,et al.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.

[71]  B. Felding-Habermann,et al.  Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. , 2010, The American journal of pathology.

[72]  W. Streit,et al.  Role of microglia in the central nervous system's immune response , 2005, Neurological research.

[73]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[74]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.

[75]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[76]  K. Hirschi,et al.  Hemato-vascular origins of endothelial progenitor cells? , 2010, Microvascular research.

[77]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.

[78]  D. Hicklin,et al.  Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors , 2006, Science.

[79]  J. Li,et al.  Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. , 2000, Cancer research.

[80]  L. Ricci-Vitiani,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[81]  R. Ádány,et al.  Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.

[82]  I. Fidler,et al.  Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. , 2009, Cancer research.

[83]  B. Badie,et al.  Expression of Fas ligand by microglia: possible role in glioma immune evasion , 2001, Journal of Neuroimmunology.

[84]  B. Felding-Habermann,et al.  Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain , 2009, Proceedings of the National Academy of Sciences.

[85]  M. Sporn,et al.  The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.

[86]  J. Julien,et al.  Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.

[87]  X. Moore,et al.  Endothelial progenitor cells’ ‘homing’ specificity to brain tumors , 2004, Gene Therapy.

[88]  D. Ojha A computational analysis of ordering in ABCHN at the nematic–isotropic transition , 2006, Journal of molecular modeling.

[89]  Gerhard Christofori,et al.  The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.

[90]  J. Antel,et al.  Expression and Modulation of HLA-DR on Cultured Human Adult Astrocytes , 1991, Journal of neuropathology and experimental neurology.

[91]  David E. Anderson,et al.  Astrocytic Regulation of Human Monocytic/Microglial Activation1 , 2008, The Journal of Immunology.

[92]  M. Graeber,et al.  Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.

[93]  K. Franks,et al.  Overview of the diagnosis and management of brain, spine, and meningeal metastases , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[94]  P. Shannon,et al.  Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1. , 2005, Neoplasia.

[95]  Z. Werb,et al.  PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.

[96]  F. Sotgia,et al.  Towards a new “stromal-based” classification system for human breast cancer prognosis and therapy , 2009, Cell cycle.

[97]  Y. Olsson,et al.  Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells , 1995, Journal of the Neurological Sciences.

[98]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[99]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[100]  Isaac Yang,et al.  The role of microglia in central nervous system immunity and glioma immunology , 2010, Journal of Clinical Neuroscience.

[101]  D. Pardoll,et al.  Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells , 2005, Neurological research.

[102]  W. Cavenee,et al.  Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. , 2001, Cancer research.

[103]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[104]  D. Scadden,et al.  Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. , 2006, Cancer research.

[105]  R. Sawaya,et al.  Management of brain metastases: the indispensable role of surgery , 2009, Journal of Neuro-Oncology.

[106]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[107]  P. Kelly,et al.  Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. , 2009, Journal of neurosurgery.

[108]  S. Renninger,et al.  Minor Contribution of Bone Marrow‐Derived Endothelial Progenitors to the Vascularization of Murine Gliomas , 2003, Brain pathology.

[109]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[110]  B. Bay,et al.  Differential Reactions of Microglia to Brain Metastasis of Lung Cancer , 2006, Molecular medicine.

[111]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[112]  J. Buckner,et al.  The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. , 2007, Neuro-oncology.

[113]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[114]  Y. Sawamura,et al.  Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes. , 1990, Journal of neurosurgery.

[115]  P. Steeg,et al.  Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.

[116]  K. Toyka,et al.  In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells , 1994, Neuroscience Letters.

[117]  W. You,et al.  Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. , 2010, Developmental biology.

[118]  C. Bucana,et al.  Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. , 1992, The American journal of pathology.

[119]  Seung-Ki Kim,et al.  Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression , 2006, Clinical Cancer Research.

[120]  I. Fidler,et al.  Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. , 2009, International journal of oncology.

[121]  R. Tanaka,et al.  Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation , 2000, Journal of Neuroimmunology.

[122]  Y. Olsson,et al.  Hematogenous metastases of the human brain – Characteristics of peritumoral brain changes: A review , 1997, Journal of Neuro-Oncology.

[123]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[124]  F. Heppner,et al.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.

[125]  M. Sofroniew,et al.  Reactive Astrocytes in Neural Repair and Protection , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[126]  A. Straube,et al.  Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro , 2011, Journal of Neuro-Oncology.

[127]  N. Van Rooijen,et al.  Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.

[128]  P. Vajkoczy,et al.  Circulating endothelial progenitor cells in malignant gliomas. , 2010, Journal of neurosurgery.

[129]  Nico van Rooijen,et al.  Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.

[130]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[131]  Peter Canoll,et al.  Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis , 2006, Glia.

[132]  M. Berger,et al.  Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis. , 2006, The Journal of biological chemistry.

[133]  W. You,et al.  Tumorigenesis and Neoplastic Progression Collagen VI Ablation Retards Brain Tumor Progression Due to Deficits in Assembly of the Vascular Basal Lamina , 2012 .

[134]  A. Sica,et al.  A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.

[135]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[136]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[137]  S. Sengupta,et al.  Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma , 2010, PloS one.

[138]  B. Döme,et al.  A Novel Concept of Glomeruloid Body Formation in Experimental Cerebral Metastases , 2003, Journal of neuropathology and experimental neurology.

[139]  C. Bucana,et al.  The seed and soil hypothesis: vascularisation and brain metastases. , 2002, The Lancet. Oncology.

[140]  Behnam Badie,et al.  Role of microglia in glioma biology , 2001, Microscopy research and technique.

[141]  F. Gage,et al.  Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes , 1991, Brain Research.

[142]  J. J. Bernstein,et al.  Glioblastoma Cells Do Not Intravasate into Blood Vessels: 124 , 1995, Neurosurgery.

[143]  Tracy T Batchelor,et al.  AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.

[144]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[145]  N. Davoust,et al.  From bone marrow to microglia: barriers and avenues. , 2008, Trends in immunology.

[146]  Yoon Kyung Choi,et al.  Blood-brain barrier interfaces and brain tumors , 2006, Archives of pharmacal research.

[147]  Philippe Soriano,et al.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.

[148]  I. Bechmann,et al.  Astrocyte-induced T cell elimination is CD95 ligand dependent , 2002, Journal of Neuroimmunology.

[149]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[150]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[151]  K. Aldape,et al.  Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. , 2010, Neoplasia.

[152]  M. Berger,et al.  Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. , 1999, Neuro-oncology.

[153]  W. Hickey,et al.  Contents , 2004, Journal of Neuro-Oncology.

[154]  B. Brew,et al.  Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification , 2004, Journal of leukocyte biology.

[155]  V. Nguyen,et al.  Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF‐β, IL‐4, IL‐13 and IL‐10 , 1999, European journal of immunology.

[156]  Alberto Mantovani,et al.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.

[157]  D. Hess,et al.  Hematopoietic origin of microglial and perivascular cells in brain , 2004, Experimental Neurology.

[158]  D. Waisman,et al.  Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade , 2003, The Journal of Neuroscience.

[159]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[160]  L. Naldini,et al.  Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. , 2004, The Journal of clinical investigation.

[161]  W. Thomas,et al.  Cellular forms and functions of brain microglia , 1994, Brain Research Bulletin.

[162]  M. Manns,et al.  Myeloid derived suppressor cells in human diseases. , 2011, International immunopharmacology.

[163]  Suyun Huang,et al.  Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.

[164]  W. Roggendorf,et al.  Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.

[165]  H. Wilms,et al.  In vitro-staining specificity of the antibody 5-D-4 for microglia but not for monocytes and macrophages indicates that microglia are a unique subgroup of the myelomonocytic lineage , 1999, Journal of Neuroimmunology.

[166]  J. Tonn,et al.  Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. , 1997, Anticancer research.

[167]  A. Vortmeyer,et al.  Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization , 2008, Clinical & Experimental Metastasis.

[168]  V. Tse,et al.  The cancer stem cell-vascular niche complex in brain tumor formation. , 2008, Stem cells and development.

[169]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[170]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[171]  S. Vandenberg,et al.  Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. , 2008, Neuro-oncology.

[172]  J. Talmadge Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy , 2007, Clinical Cancer Research.

[173]  M. Mrugala,et al.  Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. , 2009, Neurology.

[174]  A. Zeiher,et al.  Mobilizing endothelial progenitor cells. , 2005, Hypertension.

[175]  Andrea Falini,et al.  Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.

[176]  I. Nir,et al.  Permeability of blood vessels in experimental gliomas: uptake of 99mTc-glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy. , 1989, Neurosurgery.